Huntingtons Disease Topics

The On-Topic Netowork

Huntingtons Disease > Inhibition


Inhibition
Inhibition
Inhibition
Inhibition
Inhibition

The following information is about Inhibition.

Inhibition Defined

One of the responses caused by specific neurotransmitters binding to receptors on a neuron. Inhibition decreases the probability that neurotransmitters will be released by the neuron.

This definition is in context to Huntingtons Disease. See more contextual defintions for Inhibition.


Navigation: [ 1 2 3 Next ]

Triple antiplatelet therapy appears superior to dual antiplatelet therapy

Published October 12, 2008, 9:22 am, EurekAlert!

( Cardiovascular Research Foundation ) Results of five research studies and a clinical registry first-report presentation scheduled for the 20th annual Transcatheter Cardiovascular Therapeutics scientific symposium, sponsored by the Cardiovascular Research Foundation, suggest that triple antiplatelet therapy for patients undergoing percutaneous coronary intervention with drug-eluting stents ...

Full Story


Early Data Show Potential For Imatinib To Treat Life-threatening Form Of Pulmonary Artery Disease

Published October 11, 2008, 4:07 am, Medical News Today

An early proof-of-concept study presented shows promising results for imatinib in the treatment of pulmonary arterial hypertension (PAH), a severe, incurable blood vessel disorder.

Full Story


My Pharmiweb.com

Published October 10, 2008, 8:25 am, PharmiWeb

Paris, France, October 2nd, 2008 – Alexion (NASDAQ: ALXN) has received a Prix Galien USA 2008 Award for Best Biotechnology Product for Soliris® (eculizumab).

Full Story


Lilly Acquires ImClone Systems In $6.5B Transaction

Published October 10, 2008, 3:08 am, PharmaceuticalOnline

Eli Lilly and Company and ImClone Systems Inc. recently announced that the boards of directors of both companies have approved a definitive merger agreement under which Lilly will acquire ImClone through an all cash tender offer of $70.00 per share, or approximately $6.5B.

Full Story


Anti-S1P Antibody Treatment Produces Near-Complete Mitigation Of Choroidal Neovascularization In AMD Model

Published October 9, 2008, 7:45 am, Medical News Today

Lpath, Inc. (OTCBB: LPTN) announced it has published two papers showing the role of sphingosine-1-phosphate (S1P) in ocular disorders. Dr. Maria Grant's laboratory at the University of Florida collaborated with Lpath on both papers.

Full Story


Toward An Effective Treatment For A Major Hereditary Disease, Spinal Muscular Atrophy - ACS Chemical Biology

Published October 9, 2008, 6:09 am, Medical News Today

Scientists are reporting a key advance toward developing the first effective drug treatment for spinal muscular atrophy (SMA), a genetic disease that involves motor neuron loss and occurs in 1 out of every 6,000 births. SMA is the leading cause of hereditary infant death in the United States. The study is scheduled for publication online Oct. 8 by ACS Chemical Biology, a monthly journal.

Full Story


Early Data Show Potential For Imatinib Mesylate Tablets To Treat Life-Threatening Form Of Pulmonary Artery Disease

Published October 9, 2008, 3:06 am, Medical News Today

An early proof-of-concept study presented shows promising results for imatinib mesylate in the treatment of pulmonary arterial hypertension (PAH), a severe, incurable blood vessel disorder.

Full Story


Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of ...

Published October 8, 2008, 3:30 am, PR Newswire via Yahoo! Finance

Vical Incorporated today is presenting expanded clinical data and new nonclinical data demonstrating that the company's Vaxfectin® adjuvant may be broadly applicable in DNA- and protein-based infectious disease vaccines and peptide-based cancer vaccines.

Full Story


Researchers Unravel New Aspects Of The Male Hormone (Androgen) Receptor Regulation In Prostate Cancer

Published October 8, 2008, 3:08 am, Medical News Today

A team of researchers in the Center for Prostate Disease Research (CPDR) at the Uniformed Services University of the Health Sciences (USU), led by Dr. Shiv Srivastava, professor of surgery, are working to define male hormone regulated transcriptome in prostate cancer cells.

Full Story


Early data show potential for imatinib to treat life-threatening form of pulmonary artery disease

Published October 7, 2008, 10:34 pm, n-tv.de

Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Full Story


Navigation: [ 1 2 3 Next ]

Are you looking for additional Huntingtons Disease > Inhibition news? Try our new "Inhibition News Focus" area.

Off-site Inhibition Links, User Submitted

The following links have been collected through user bookmark submission in the Inhibition category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Sat Oct 4

Wed Oct 1

Fri Sep 26

Thu Sep 25

Wed Sep 24

Tue Sep 16

Mon Sep 15

Tue Sep 9

  • Ultra Hair Away: Ultra hair away is a new generation in hair inhibition. Now there is no need to shave hairs every second day. Just spray ultra hair away after shaving or removing your hairs. And the growth of hair will be ultra slow. Not only it stops hair growth but also it makes hair small, thin and smooth so that after every use of ultra hair away, you will find hairs are getting disapeared. Ultra hair away is completely natural formulation thus causing no side effects. Its composed of 100% natural herbs.

Mon Sep 1

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Inhibition. If you would like to find related tags we recommend Tag Patterns > Inhibition

Off-site Inhibition Research Links

If you still need additional information on Inhibition then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Huntingtons Disease

If you know the Huntingtons Disease Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Huntingtons-Disease.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a